| 臺大學術典藏 |
2022-09-06T07:43:41Z |
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
|
Wu C.-Y.; MING-SHIANG WU; Chiang E.-P.; Wu C.-C.; Chen Y.-J.; Chen C.-J.; Chi N.-H.; Chen G.-H.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:37Z |
Helicobacter pylori infection in the elderly
|
Liou J.-M.; Lin J.-T.; Lee Y.-C.; Wu C.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T07:43:36Z |
Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma
|
Liao W.-C.; Lin J.-T.; Wu C.-Y.; Huang S.-P.; Lin M.-T.; Wu A.S.-H.; Huang Y.-J.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T07:43:36Z |
RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women
|
Liou J.-M.; Lin J.-T.; Huang S.-P.; Wu C.-Y.; Wang H.-P.; Lee Y.-C.; Chiu H.-M.; Shun C.-T.; Lin M.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T07:43:34Z |
Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer
|
Wu C.-Y.; MING-SHIANG WU; Chen Y.-J.; Chen H.-P.; Chen C.-J.; Chang C.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:24Z |
Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel
|
Wu C.-Y.; Chan F.K.-L.; MING-SHIANG WU; Kuo K.N.; Wang C.-B.; Tsao C.-R.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:22Z |
Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients
|
Wu C.-Y.; MING-SHIANG WU; Kuo K.N.; Wang C.-B.; Chen Y.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:17Z |
Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: A 10-year nationwide cohort study
|
Wu C.-Y.; MING-SHIANG WU; Kuo K.N.; Wang C.-B.; Chen Y.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:11Z |
Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study
|
Hsu Y.-C.; Lin J.-T.; Chen T.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:10Z |
Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection
|
Wu C.-Y.; Chen Y.-J.; Ho H.J.; Hsu Y.-C.; Kuo K.N.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:08Z |
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer
|
Lee T.-Y.; Lin J.-T.; Wu C.-C.; Yu C.-C.; MING-SHIANG WU; Lee T.-C.; Chen H.-P.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:07Z |
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: Population-based and in vitro studies
|
Chen H.-P.; Shieh J.-J.; Chang C.-C.; Chen T.-T.; Lin J.-T.; MING-SHIANG WU; Lin J.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:07Z |
A nationwide population-based study shows increasing incidence of cholangiocarcinoma
|
Lee T.-Y.; Lin J.-T.; Kuo K.N.; MING-SHIANG WU; Ho H.J.; Chen T.-T.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:07Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:06Z |
Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
|
Hsu Y.-C.; Ho H.J.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:04Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU; Kuo K.N.; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:02Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu Y.-C.; Lin J.-T.; Ho H.J.; Kao Y.-H.; Huang Y.-T.; Hsiao N.-W.; MING-SHIANG WU; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:00Z |
Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance
|
Sheu B.-S.; Wu C.-Y.; MING-SHIANG WU; Chiu C.-T.; Lin C.-C.; Hsu P.-I.; Cheng H.-C.; Lee T.-Y.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T02:41:38Z |
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
|
Chan C.-K.; Chang Y.-Y.; Tsai Y.-C.; Chen Z.-W.; Wu C.-Y.; Huang W.-C.; Yen I.-W.; Wu K.-H.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; LIAN-YU LIN; Hu F.-C.; Chang C.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Jeff Chueh S.-C.; Liao S.-C.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:14Z |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Hsieh F.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-12T06:28:59Z |
Microcalcifications of non-palpable breast lesions detected by ultrasonography: Correlation with mammography and histopathology
|
Huang C.-S.; Wu C.-Y.; Chu J.-S.; Lin J.-H.; Hsu S.-M.; KING-JEN CHANG |
